Turnaround signs have begun to appear, evidenced by a return of positive comps across brands so far in FY 2024.

Related: Analyst revises AbbVie stock price target on drug-sale estimates Sales eroded, however, as Humira faced competition ...

Meta Platforms (NASDAQ: META) is scheduled to report its results for the third quarter on Oct. 30. Besides analyzing the ...

A new study finds that is particularly true for people nearing retirement.

On the winning side of Wall Street was Intuitive Surgical, which climbed 8.5% after reporting stronger profit for the latest ...

U.S. stocks were higher, with the Dow on pace for another record close, though equities were off their best levels of the ...

America’s largest drug store chain named a new chief executive officer on Friday, with longtime CVS Health executive David ...

The platform’s total subscriber count is expected to hit nearly 282 million in the latest quarter, a jump from last year’s ...

The Dutch chipmaker’s third-quarter results missed estimates and were published a day earlier than expected due to a ...

World shares are mostly lower after U.S. stocks pulled back from their records, dented by selling of technology and ...

Troubled Stellantis was downgraded again Wednesday by a credit rating agency, and its shares have now fallen more than 50% ...

Apple shares hit a new record high Tuesday, the same day the tech giant unveiled the latest version of its Apple Intelligence ...